+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | HIV-1 Nuclear Condensate under NEV treatment | |||||||||
Map data | Nuclear HIV-CPSF6 site in infected cells treated with NEV | |||||||||
Sample |
| |||||||||
Keywords | HIV-1 nuclear condensates / CPSF6 / Capsid / Nevirapine / immuno-gold labelling / VIRUS | |||||||||
| Biological species | HIV-1 vector pNL4-3 (others) | |||||||||
| Method | electron tomography / negative staining | |||||||||
Authors | Gazi AD / Burlaud-Gaillard J / Roingeard P / Di Nunzio F | |||||||||
| Funding support | France, 2 items
| |||||||||
Citation | Journal: EMBO J / Year: 2025Title: In vivo HIV-1 nuclear condensates safeguard against cGAS and license reverse transcription. Authors: Selen Ay / Julien Burlaud-Gaillard / Anastasia Gazi / Yevgeniy Tatirovsky / Celine Cuche / Jean-Sebastien Diana / Viviana Scoca / James P Di Santo / Philippe Roingeard / Fabrizio Mammano / Francesca Di Nunzio / ![]() Abstract: Entry of viral capsids into the nucleus induces the formation of biomolecular condensates called HIV-1 membraneless organelles (HIV-1-MLOs). Several questions remain about their persistence, in vivo ...Entry of viral capsids into the nucleus induces the formation of biomolecular condensates called HIV-1 membraneless organelles (HIV-1-MLOs). Several questions remain about their persistence, in vivo formation, composition, and function. Our study reveals that HIV-1-MLOs persisted for several weeks in infected cells, and their abundance correlated with viral infectivity. Using an appropriate animal model, we show that HIV-1-MLOs were formed in vivo during acute infection. To explore the viral structures present within these biomolecular condensates, we used a combination of double immunogold labeling, electron microscopy and tomography, and unveiled a diverse array of viral core structures. Our functional analyses showed that HIV-1-MLOs remained stable during treatment with a reverse transcriptase inhibitor, maintaining the virus in a dormant state. Drug withdrawal restored reverse transcription, promoting efficient virus replication akin to that observed in latently infected patients on antiretroviral therapy. However, when HIV-1 MLOs were deliberately disassembled by pharmacological treatment, we observed a complete loss of viral infectivity. Our findings show that HIV-1 MLOs shield the final reverse transcription product from host immune detection. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_51466.map.gz | 1.6 GB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-51466-v30.xml emd-51466.xml | 16.6 KB 16.6 KB | Display Display | EMDB header |
| Images | emd_51466.png | 217.4 KB | ||
| Filedesc metadata | emd-51466.cif.gz | 4.5 KB | ||
| Others | emd_51466_additional_1.map.gz emd_51466_additional_2.map.gz emd_51466_additional_3.map.gz | 21.3 MB 27.1 MB 41.8 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-51466 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-51466 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_51466.map.gz / Format: CCP4 / Size: 2.5 GB / Type: IMAGE STORED AS SIGNED INTEGER (2 BYTES) | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Nuclear HIV-CPSF6 site in infected cells treated with NEV | ||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. generated in cubic-lattice coordinate | ||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 4.032 Å | ||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Additional map: Manually annotated Dense HIV cores
| File | emd_51466_additional_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Manually annotated Dense HIV cores | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Additional map: Manually Annotated Lighter HIV Cores
| File | emd_51466_additional_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Manually Annotated Lighter HIV Cores | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Additional map: Manually Annotated Ghost HIV Cores
| File | emd_51466_additional_3.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Manually Annotated Ghost HIV Cores | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : THP-1 cells infected with HIV-1 and treated with Nevirapine (NEV)
| Entire | Name: THP-1 cells infected with HIV-1 and treated with Nevirapine (NEV) |
|---|---|
| Components |
|
-Supramolecule #1: THP-1 cells infected with HIV-1 and treated with Nevirapine (NEV)
| Supramolecule | Name: THP-1 cells infected with HIV-1 and treated with Nevirapine (NEV) type: cell / ID: 1 / Parent: 0 Details: Double immunolabelled Tokuyasu style sections of HIV infected cells. HIV cores found in an CPSF6 nuclear condensate (10nm immunogold targets CPSF6, 6nm gold the HIV capsid protein) |
|---|---|
| Source (natural) | Organism: HIV-1 vector pNL4-3 (others) |
-Experimental details
-Structure determination
| Method | negative staining |
|---|---|
Processing | electron tomography |
| Aggregation state | cell |
-
Sample preparation
| Buffer | pH: 7.6 |
|---|---|
| Staining | Type: NEGATIVE / Material: 2% Uranyl Acetate |
| Grid | Material: NICKEL |
| Details | Infected cells were sectioned using the Tokuyasu protocol and immunolabelled against CPSF6 (10nm beads) and capsid protein (6nm beads) |
| Sectioning | Ultramicrotomy - Instrument: Leica EM UC7 / Ultramicrotomy - Temperature: 153 K / Ultramicrotomy - Final thickness: 80 |
-
Electron microscopy
| Microscope | JEOL 1400 |
|---|---|
| Details | Classical TEM imaging using contrasting agent. Preliminary grid screening performed manually. |
| Image recording | Film or detector model: OTHER / Digitization - Dimensions - Width: 4096 pixel / Digitization - Dimensions - Height: 4096 pixel / Number real images: 230 / Average electron dose: 200.0 e/Å2 Details: Classical TEM imaging under high dose conditions. Prior data acquisition mild cooking took place in middle magnifications. |
| Electron beam | Acceleration voltage: 120 kV / Electron source: LAB6 |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.5 µm |
| Sample stage | Specimen holder model: SIDE ENTRY, EUCENTRIC |
-
Image processing
| Details | Gatan ONeView |
|---|---|
| Final reconstruction | Algorithm: BACK PROJECTION / Software - Name: IMODDetails: Back projection in IMOD using the SIRT-like filter (12 iterations) of axes A and B. Number images used: 230 |
Movie
Controller
About Yorodumi




Keywords
Authors
France, 2 items
Citation
Z (Sec.)
Y (Row.)
X (Col.)








































IMOD